# Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure

> **NCT02787798** · PHASE4 · TERMINATED · sponsor: **University Hospital, Toulouse** · enrollment: 4 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** valsartan/sacubitril 100 mg
- **DRUG:** valsartan/sacubitril 200 mg
- **PROCEDURE:** Microneurography

## Key facts

- **NCT ID:** NCT02787798
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Today Entresto treatment has marketing authorization and is available for all patients, that is the reason why study was halted prematurely.
- **Last updated:** 2019-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787798, "Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02787798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*